NLRP3 Inflammasome Exhibits Context-Dependent Roles in Glioblastoma-Astrocyte Crosstalk
Rajkhowa, S.; Sha, L.; Meena, D.; Kumar, D.; Revanth, M.; Janu, V.; Garg, M.; Agrawal, M.; Jha, D.; Jha, S.
Show abstract
Glioblastoma (GBM) is a highly aggressive brain tumor characterized by molecular and cellular heterogeneity and poor patient survival. NLRP3 inflammasome regulates inflammation and cell death with context-specific roles in cancer, but its functions in GBM tumour and astrocyte interactions remain unclear. In this study, we analyzed NLRP3 expression and function in GBM cell lines (LN-229 and LN18), astrocytes (SVG), patient-derived tissues, and organoids. Basal NLRP3 expression was higher in astrocytes than in GBM cells and increased after LPS stimulation, altering astrocyte morphology and NLRP3 subcellular localization. siRNA-mediated silencing of NLRP3 reduced GBM proliferation, migration, and viability in GBM cells, while enhancing proliferation and cytokine secretion in astrocytes, highlighting its context-dependent effects. NLRP3 deficiency exhibited reciprocal cytokine paracrine signaling, with GBM cells releasing elevated levels of IL-6 and TNF-, and astrocytes releasing elevated levels of IL-1{beta}. Glyburide treatment reduced NLRP3 expression and IL-1{beta} release in GBM cells but elevated NLRP3 and IL-1{beta} in astrocytes. Overall, these data reveal NLRP3s dual roles in GBM-astrocyte crosstalk, suggesting cell-type-selective inhibition for therapeutic exploration.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Novel kinome profiling technology reveals drug treatment is patient and 2D/3D model dependent in GBM 95%
- High Affinity Chimeric Antigen Receptor with Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms 94%
- AATF Inhibition Exerts Antiangiogenic Effects AgainstHuman Hepatocellular Carcinoma 94%
Similar papers in this journal
- Changes in the tumor microenvironment and treatment outcome in glioblastoma: A pilot study 95%
- Evaluating soluble Axl as a biomarker for glioblastoma: a pilot study 95%
- Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative Splicing 95%
Similar papers in this journal
- THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progression 95%
- Subclonal evolution and expansion of THY1-positive cells is associated with recurrence in glioblastoma 93%
- Disruption of redox balance in glutaminolytic triple negative breast cancer by inhibition of glutamate export and glutaminase 92%
Similar papers in this journal
Similar papers in this journal
- LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population During Temozolomide Therapy in Glioblastoma 96%
- Profiling anti-apoptotic protein BCL-xL expression in U-87 MG glioblastoma cells and patient-derived tumorspheres 96%
- Tyrosyl-DNA phosphodiesterase 1 and topoisomerase I activities as predictive indicators for Glioblastoma susceptibility to genotoxic agents 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.